Hypoxia-inducible factor (HIF) has important roles in promoting pro-inflammatory and bactericidal functions in myeloid cells. Conditional genetic ablation of its major subunit Hif1 in the myeloid lineage consequently results in decreased inflammatory responses in classical models of acute inflammation in mice. By contrast, we report here that mice conditionally deficient for Hif1 in myeloid cells display enhanced sensitivity to the development of airway allergy to experimental allergens and house-dust mite antigens. We support that upon allergen exposure, MyD88-dependent upregulation of Hif1 boosts the expression of the immunosuppressive cytokine interleukin (IL)-10 by lung interstitial macrophages (IMs). Hif1 -dependent IL-10 secretion is required for IMs to block allergen-induced dendritic cell activation and consequently for preventing the development of allergen-specific T-helper cell responses upon allergen exposure. Thus, this study supports that, in addition to its known pro-inflammatory activities, myeloid Hif1 possesses immunoregulatory functions implicated in the prevention of airway allergy.
INTRODUCTION
Airway allergy, with allergic asthma being its most severe manifestation, is a highly prevalent chronic inflammatory disease that has reached epidemic proportions in developed countries. 1 It is now well accepted that airway allergy primarily originates from the activation of dendritic cells (DCs) and the subsequent differentiation of type 2 T helper (Th2) cells in response to allergen exposure. 2 -4 Although the cellular and molecular mechanisms governing the development of airway allergy are starting to be well characterized, much less is known of the mechanisms that prevent the disease in healthy individuals. Yet, the identification of these mechanisms may be key to our understanding of the origins of the current airway allergy epidemic, as well as to the needed improvement of prevention strategies. 1 Although a role for regulatory T cells in maintaining immune tolerance to aeroallergens has been documented in different contexts, 5, 6 innate myeloid cell-mediated mechanisms seem equally important. The most documented examples to date relate to the immunoregulatory activities of lung macrophages. Two subsets of lung macrophages have been described in mice and humans, namely alveolar macrophages (AMs) and interstitial macrophages (IMs), which together represent the most abundant immune cell populations in the healthy lung. 7, 8 AMs and IMs were reported to counteract the development of adaptive immune responses by inhibiting DC function. 9 -11 Because they are able to break the DC-mediated link between innate and adaptive immunity, AMs and IMs thus may act as firstline brakes to the development of undue immune responses to harmless inhaled antigens. Of note however, inflammatory cytokines, such as granulocyte macrophage-colony stimulating factor (GM-CSF), which are induced by common allergens and environmental Toll-like receptor (TLR) ligands, 12, 13 alleviate the immunosuppressive functions of AMs. 14 AMs were thus proposed to act as suppressors mainly in the absence of immunostimulatory signals in the steady state. Yet, ambient air contains a variety of immunostimulatory molecules of microbial origin, many of which are TLR ligands. 15 -17 IMs react to TLR activation by upregulating their production of the immunosuppressive cytokine interleukin (IL)-10, a feature absent in AMs. 11 This allows IMs to inhibit DC function, and thereby the development of adaptive immune responses, in experimental Myeloid hypoxia-inducible factor 1 prevents airway allergy in mice through macrophagemediated immunoregulation ARTICLES models of common environmental conditions where aeroallergens are inhaled concomitantly to ambient immunostimulatory molecules. 11 In spite of their potential relevance to the understanding of pulmonary immune homeostasis, the mechanisms implicated in the function of lung macrophages as myeloid regulators remain largely uncharacterized.
Hypoxia-inducible factor (HIF) is a ubiquitously expressed transcription factor mainly known for its prominent roles in regulating cellular responses to hypoxia. 18 HIF is composed of the constitutively expressed Hif1 subunit (also known as ARNT) and either one of the two inducible -subunits Hif1 and Hif2 . 19 Hif1 is expressed ubiquitously, whereas expression of Hif2 is more restricted. The half-life of Hif subunit proteins increases under hypoxia due to the inhibition of the activity of oxygen-and iron-dependent prolyl hydroxydases, which target them for proteosomal degradation under normoxic conditions. 20, 21 Because of its role in the adaptation of cell metabolism to hypoxia, it was proposed that HIF is an important promoter of inflammatory responses, which require innate immune cells to migrate against oxygen gradients and to adapt to oxygendeprived inflammatory environments. 22 Indeed, mice conditionally deficient for Hif1 in myeloid cells display impaired inflammatory responses in classical models of inflammation such as forbol ester-or sodium dodecylsulfate-induced acute skin inflammation and arthritis induced by transfer of autoimmune serum. 23 Myeloid HIF may also delay inflammation resolution by promoting neutrophil survival and retention at sites of inflammation. 24, 25 The link between HIF and inflammation was further strengthened by the realization that HIF engages in crosstalk with another major pathway of immunity, the nuclear factor (NF)-B pathway. Indeed, NF-B activity upregulates Hif1 gene transcription in hypoxic conditions. 26 Reciprocally, HIF may positively regulate NF-B activity 24 and NF-B-dependent gene expression. 27 Although most studies focused on hypoxic conditions, HIF promotes bactericidal and inflammatory functions of myeloid cells also in normoxia. 28 -30 Indeed, stimuli such as TLR ligands or inflammatory cytokines are potent inducers of HIF activity in normoxic conditions through the activation of NF-B-dependent Hif1 transcription. 28 -31 Here, using mouse models of conditional Hif1 deficiency, we report that, contrasting with its recognized pro-inflammatory functions, myeloid Hif1 counteracts the development of airway allergic inflammation to experimental aeroallergens and house-dust mite (HDM) antigens. We propose that myeloid Hif1 mediates these anti-inflammatory effects by positively regulating the IL-10-dependent suppressive activity of IMs on DCs upon TLR activation. Our results thus support a previously unappreciated role of HIF in maintaining mucosal immune homeostasis toward allergens in the lung.
RESULTS

Mice deficient for Hif1 in myeloid cells display exacerbated airway allergy to HDM antigens
In order to study the role of Hif1 in cells of the myeloid lineage in airway allergy, we used the model of conditional genetic deletion used by Cramer et al. 23 Figure 1c ). Approximately 30 % Hif1 gene deletion was also observed in lung DCs, which probably is explained by the monocytic origin of a fraction of lung DCs. 32 In order to compare their response to common aeroallergens, we exposed Hif1 m − / − and Hif1 + / + mice to repeated intranasal (IN) injections of extracts of HDMs, a major source of allergens in humans. This type of regimen models physiological sensitization and elicits allergic responses that resemble human airway allergy. 33, 34 We observed that Hif1 m − / − mice displayed exacerbated responses to HDM for all of the tested parameters of airway allergy. Indeed, when compared with Hif1 + / + mice, Hif1 m − / − mice had increased inflammatory cell infiltration and mucus production in their airways ( Figure 2a -c ) . Hif1 m − / − mice also showed increased airway resistance in response to metacholine challenge compared with control mice, as assessed using invasive measurement of dynamic resistance in mechanically ventilated mice ( Figure 2d ) These results supported that Hif1 m − / − mice are more prone to the development of Th2 responses, the main orchestrators of airway allergy, than are control mice in response to allergen exposure. Consequently, we first assessed cell proliferation and Th2 cytokine production in the lung-draining bronchial lymph nodes (BLNs) of OVA-sensitized Hif1 m − / − and Hif1 + / + mice upon in vitro OVA restimulation. We observed that BLN cells from Hif1 m − / − mice proliferated significantly more than cells from Hif1 + / + mice ( Figure 4a ). They also produced comparatively more IL-4, IL-5, and IL-13, three type 2 cytokines ( Figure 4b ). Of note, we also observed increased secretion of interferon-(IFN-), which indicates that not only the Th2 component of the allergen-specific response is increased in Hif1 m − / − mice ( Figure 4b ). Second, we more directly studied antigen-specific T-cell proliferation by assessing the division index of adoptively transferred carboxyfluorescein succinimidyl ester (CFSE)-labeled OVA-specific OT-II cells following a sin- ( Figure 4g,h ). Taken together, these results indicate that the absence of Hif1 in myeloid cells facilitates Th cell differentiation in response to inhaled allergens.
Hif1 in lung IMs prevents allergen-induced DC activation
The above results indicate that Hif1 m − / − mice display an overall increase in allergen-specific T-cell responses, characterized by the increased secretion of prototypical type 2 cytokines as well as IFN-. This may have been indicative of facilitated antigen presentation by DCs, the main triggers of allergen-specific Th cell differentiation following allergen exposure. 35 We therefore compared the behavior of lung DCs in Hif1 m − / − and Hif1 + / + mice. We observed that significantly more DCs transported antigen to the BLNs of Hif1 − / − mice after exposure to fluorescein isothiocyanate (FITC)-labeled OVA ( Figure 5a,b ) .
This observation suggested that a brake to DC activation by allergens was lost following deletion of myeloid Hif1 . We therefore studied the effect of myeloid Hif1 deletion on the function of IMs and AMs, which were previously shown to counteract DC activation following antigen exposure. 10, 11 To compare the immunosuppressive function of control and Hif1 − / − IMs on DCs, we isolated IMs from Hif1 m − / − and Hif1 + / + mice and cultured them with syngeneic WT bone marrow -derived DCs (BMDCs).
Overnight pulse with OVA induces the maturation of BMDCs, as indicated by their increased levels of cell-sur- ( Figure 6b -e ) . Accordingly, BLN cell proliferation and Th2 cytokine secretion were comparable in mice that received BMDCs co-cultured with Hif1 − / − IMs and mice that received BMDCs alone, whereas they were significantly inhibited in mice that received BMDCs co-cultured with control IMs ( Figure 6f,g ).
These 
MyD88-dependent activation of Hif1 boosts the immunosuppressive activity of IMs
We aimed to determine how allergens may upregulate Hif1 activity in IMs, and how Hif1 may in turn impact on IM regulatory activity. HDM preparations notably contain LPS, and the major dust mite allergen Der p 2 was shown to mimic the structure and activity of the MD2 subunit of the endotoxin receptor complex. 36 We thus suspected that, as shown in other experimental contexts, 29 TLR engagement by HDM may promote Hif1 gene transcription in IMs. We indeed observed that HDM-induced upregulation of Hif1 mRNA expression was abrogated in MyD88-deficient IMs ( Figure 7a ).
IMs were previously shown to inhibit DC function by their upregulation of IL-10 secretion in response to TLR activation. 11 We observed that Hif1 − / − IMs secreted significantly less IL-10 than their control counterparts in response to HDM, while their production of transforming growth factor-(TGF-) was comparable ( Figure 7b ).
We consequently further tested the role of IL-10 in the regulatory activity of IMs, and whether impaired secretion of IL-10 accounts for the deficient activity of Hif1 − / − IMs. In coculture experiments in which IMs were separated of BMDCs by a semipermeable membrane, we neutralized IL-10 secreted by Hif1 + / + IMs using monoclonal antibodies. Symmetrically in a similar setting, we complemented the supernatant of co-cultures of BMDCs and Hif1 − / − IMs with recombinant Altogether, these results support that Hif1 controls the immunoregulatory activity of IMs toward DCs by upregulating their production of IL-10 in response to TLR activation and that Hif1-dependent IL-10 secretion in turns counteracts airway allergic sensitization.
DISCUSSION
Airway allergy results from the development of aberrant adaptive responses against common environmental aeroantigens. We show here that deletion of Hif1 in myeloid cells unexpectedly results in increased sensitivity to airway allergy in mice. This observation supports the existence of previously unappreciated Hif-1-dependent protective mechanisms responsible for So far, known mechanisms of Hif1 -dependent protection of mucosal surfaces mainly involved Hif1 as a promoter of the bactericidal and inflammatory function of myeloid cells, actively protecting mucosal surfaces from pathogens. 22 Moreover, Hif1 was recently identified as an orchestrator of the differentiation of T cells into Th17 cells and as a negative regulator of regulatory T-cell differentiation. 37, 38 By contrast with these pro-inflammatory functions of Hif1 in immune cells, epithelial Hif1 may promote the expression of anti-inflammatory mediators such as netrin-1 or key actors of adenosine metabolism and signaling, which downregulate immune cell function. 22, 39, 40 Epithelial Hif1 would in this way keep the pro-inflammatory functions of immune cells in check and protect mucosal surfaces from inflammation-induced injury.
Hif1 -dependent protection of mucosal surfaces thus so far seemed to depend on the compartmentalization of pro-and anti-inflammatory activities of Hif1 in immune and epithelial cells, respectively. Our results contrast with this clear-cut division of Hif1 function. Myeloid Hif1 could also indeed act as an early checkpoint for the development of adaptive responses against aeroantigens and thereby protect respiratory mucosal surfaces from undue inflammatory responses. In consequence, this study supports that Hif1 has an ambivalent role in immune cells, acting as a pro-inflammatory or anti-inflammatory transcription factor in a context-and celldependent manner in physiological conditions. This proposal may be related to the recent suggestion that, in pathological conditions, Hif1 may impair tumor immune surveillance by promoting immunosuppressive activities in myeloid suppressor cells. 41 
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Previous studies using widespread gene deletion or pharmacological inhibition in mice supported a neat pro-inflammatory function of HIF in airway allergy. 43, 44 Although the cellular and molecular mechanisms underlying these observations were not investigated in detail, the anti-inflammatory outcome of general HIF inhibition most likely is linked to the requirement for HIF in the maturation and function of DCs. 45 -47 Again, the fact that the outcome of HIF impairment depends on the cell types targeted highlights the importance of cellular compartmentalization in determining HIF function.
Our results support that facilitation of airway allergy development upon deletion of myeloid Hif1 occurs primarily through the loss of the immunoregulatory activity of IMs. IMs were recently proposed as essential regulators of pulmonary immune homeostasis toward aeroantigens, 11 although the mechanisms governing their function remain to be established. We observed here that IMs require intact Hif1 activity to optimally secrete IL-10 and antagonize DC activation following allergen stimulation. Hif1 activity in IMs would thereby protect respiratory mucosal surfaces from undue DC-induced adaptive immune responses. Supporting this notion, Hif1 m − / − mice and mice depleted of their IMs using depleting antibodies display comparably increased susceptibility to the development of experimental airway allergy. 11 In addition to IMs, the model of conditional ablation used in this study also induced Hif1 gene deletion in AMs, neutrophils, and a fraction of lung DCs. AMs have been reported to possess immunosuppressive activities in certain models of antigen exposure. 9, 10 However, in agreement with a previous report, we did not observe any inhibitory effect of AMs on DC function upon OVA LPS exposure in vitro . 11 Furthermore, using IT administration of clodronate-loaded liposomes to deplete AMs as in previous studies, 9, 10 it was shown that AMs are not able to interfere with allergic airway sensitization in the model of OVA-induced airway allergy used in the present study. 11 Similarly, we observed that AM depletion did not impact on the development of airway allergy in our model of HDM exposure (M. Toussaint, unpublished observations). Altogether, these observations reduce the likeliness of a role for AMs in the prevention of airway allergic sensitization through Hif1 -dependent immunoregulatory activities. We nevertheless do not rule out that AMs may impact on parameters of airway allergy in sensitized subjects through other mechanisms, as has been proposed by previous studies. 48, 49 The role of neutrophils in the pathogenesis of airway allergy is still unclear. Although potential immunoregulatory effects of certain neutrophil products have been proposed by a few in vitro studies, 50 -52 most experimental and clinical evidence tends to link neutrophils with pro-inflammatory activities and aggravated asthmatic phenotypes. 53 -55 Although we do not formally exclude this hypothesis, it is unlikely that Hif1 in neutrophils could counteract airway allergy. Finally, Hif1 has been shown to promote the pro-inflammatory and pro-Th2 functions of DCs. 45 -47 It is thus unlikely that Hif1 deletion in a fraction of lung DCs would result in anti-inflammatory activities. We thus support that, even though we do not formally exclude a putative participation of other cell types, IMs are the primary cells in which myeloid Hif1 has its immunoregulatory role in response to aeroallergens.
IMs share numerous phenotypic and functional similarities with macrophages of the intestinal lamina propria (LPMs). Indeed, both IM and LPMs share similarities in their cell-surface phenotype and react to TLR ligands by upregulating their production of IL-10, which in turn contributes to preventing the development of undue adaptive responses, respectively, in the lung 11 and intestine. 56 Although the concept is only emerging and will require further investigation, it is tempting to consider IMs and LPMs as a unique type of regulatory macrophages, in charge of ensuring immune homeostasis at mucosal sites permanently exposed to external stimuli. Even though further experiments are needed to confirm this hypothesis in LPMs, we propose that HIF activity may be a central determinant of the immunoregulatory function of regulatory macrophages at mucosal surfaces.
METHODS
Mice . Hif1 fl / fl , 57 Lysm -Cre + 58 and OVA-specific, MHC II -restricted, T-cell receptor (TCR) -transgenic OT-II (H-2b) mice were purchased from the Jackson Laboratory (Bar Harbor, ME). All transgenic mice were on a C57Bl / 6 background. All mice were bred and housed in institutional specific pathogen-free facilities. Age-paired groups of females 8 -10 weeks of age were used. All experimental procedures and protocols were approved by the Institutional Animal Care and Use Committee of the University of Liege. We also followed the " Guide for the Care and Use of Laboratory Animals " prepared by the Institute of Laboratory Animal Resources, National Research Council and published by the National Academy Press (revised 1996). Parameters of allergy in these models, including cytology of the bronchoalveolar lavage fluid, lung histology, and total IgE serum levels, were assessed as described previously. 11, 34 The extent of peribronchial inflammation was estimated by a score calculated by quantification of peribronchial inflammatory cells in lung sections stained with hematoxylin and eosin, as described previously. 11 Mucus production was quantified as percentage of periodic acid-Schiff-stained goblet cells per total epithelial cells in randomly selected bronchi. Seven randomly selected sections were analyzed per mouse lung. Airway hyper-responsiveness was evaluated by measuring dynamic airway resistance in anesthetized mice using a flexiVent small animal ventilator (SCIREQ, Tempe, AZ), as previously described. 11 Changes were expressed as percentage change from the baseline measurement (performed following PBS exposure). DC migration assay . The antigen uptake and migratory activity of lung DCs were evaluated by IT administration of 100 g FITC-labeled OVA combined with 10 ng LPS, followed 18 h later by flow cytometric analysis of the numbers of F4 / 80 − CD11c + FITC + DCs in the BLNs.
Cocultures . BMDCs were generated as described previously. 11 At day 8, the culture medium was replaced with medium devoid of GM-CSF. FACS-sorted IMs were added to BMDC cultures at a ratio of 1:1, 1 h before treatment with OVA LPS or PBS. In some experiments, BMDCs and IMs were co-cultured separated by a semi-permeable membrane (1-m pore culture inserts; BD Biosciences) with 10 g ml − 1 neutralizing anti-IL-10 antibodies or 1 ng ml − 1 recombinant mouse IL-10. On day 9, 1 × 10 6 BMDCs, alone or with the co-cultured IMs, were injected IT to recipient mice and 10 days later, mice were challenged with OVA a b 
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(1 % wt / vol in PBS; grade III; Sigma-Aldrich) aerosol during a daily 30-min challenge on 5 consecutive days. Viability of IMs and BMDCs before adoptive transfer was assessed by 7-AAD staining and flow cytometric analysis. Twenty-four hours after the last challenge, AHR was measured, the mice were killed, and airway allergy was evaluated.
Production of IL-10 and TGF-by IMs . FACS-sorted IMs were stimulated with HDM (30 g ml − 1 ) or excipient and cultivated for 16 h. Culture supernatants were assayed for IL-10 and TGF-by ELISA (eBioscience).
Quantitative PCR analysis of Hif1 and Muc5ac mRNA . For the analysis of Hif1 mRNA, the RNA of FACS-sorted IMs from mice exposed to 50 g ml − 1 HDM for 4 h was isolated using TRIzol (Invitrogen). For the analysis of Muc5ac mRNA expression, mouse lungs were crushed and homogenized in TRIzol, and RNA was extracted. One microgram of RNA by sample was used for reverse transcription reactions using the RevertAid First Strand cDNA Synthesis Kit (Fermentas, Waltham, MA). Specific primers with the following sequences were used: Hif1 -forward 5 Ј -TAAACCTGGCAATGTCTCCTT-3 Ј , Hif1 -reverse 5 Ј -TCAGTGCAGGATCAGCACTAC-3 Ј , Muc5ac -forward: 5 Ј -TACAATGGGCAACGGTACCATCCT-3 Ј , Muc5ac -reverse: 5 Ј -AACTGCAGGTGTCAACGATCCTCT-3 Ј and for the references genes: 
5 Ј -AAGATGGTGATGGGCTTCCCG-3 Ј ; Hprt -forward 5 Ј -AGCT ACTGTAATGATCAGTCAACG-3 Ј , and Hprt -reverse 5 Ј -AGAGG TCCTTTTCACCAGCA-3 Ј . Quantification and normalization of the results were performed using the qBase + software (Biogazelle, Ghent, Belgium). All samples were run in triplicate for the target and reference genes.
Statistical analysis . Data are presented as means ± standard deviation (s.d.). The differences between mean values were estimated using pairwise Student ' s t -tests following Anderson -Darling tests for assessment of normality of the data distributions. In all the figures, asterisks are used to indicate significant differences observed when comparing Hif1 + / + -and Hif1 m − / − -treated groups ( * P < 0.05, * * P < 0.01, * * * P < 0.001). 
